RBC's New European Index Notes Offer Triple Returns with Built-in Safety Features
Rhea-AI Filing Summary
Royal Bank of Canada is offering Accelerated Return Notes (ARNs) linked to the EURO STOXX 50 Index with a 14-month term. Each unit has a principal amount of $10.00 with the following key features:
- 3-to-1 upside exposure (300% participation rate) to index increases, capped at $11.50-$11.90 per unit (15-19% return)
- 1-to-1 downside exposure with full principal at risk
- No exchange listing or secondary market expected
Key risks include: potential loss of principal, credit risk of RBC, capped returns, currency exposure to the Eurozone, and limited liquidity. The notes offer enhanced upside potential but expose investors to full downside risk. The public offering price will exceed the initial estimated value, and returns may be less than direct investment in the index components.
Positive
- Offers 3-to-1 upside exposure to EURO STOXX 50 Index gains with potential returns of 15-19% over 14 months
- Provides enhanced participation rate of 300% up to the capped value, allowing amplified returns in moderately bullish scenarios
Negative
- No principal protection with full 1:1 downside exposure to index losses
- Returns are capped at $11.50-$11.90 per unit, limiting upside potential in strong bull markets
- No secondary market trading expected, limiting liquidity for investors
- Subject to Royal Bank of Canada's credit risk with no FDIC insurance
Registration
Statement No. 333-275898
Filed Pursuant to Rule 433
| ACCELERATED RETURN NOTES® (ARNs®) | |
| Accelerated Return Notes® Linked to the EURO STOXX 50® Index | |
| Issuer | Royal Bank of Canada (“RBC”). References on this page to “we,” “us” or “our” mean RBC. |
| Principal Amount | $10.00 per unit |
| Term | Approximately 14 months |
| Market Measure | The EURO STOXX 50® Index (Bloomberg symbol: “SX5E”) |
| Payout Profile at Maturity |
· 3-to-1 upside exposure to increases in the Market Measure, subject to the Capped Value · 1-to-1 downside exposure to decreases in the Market Measure, with 100% of your principal at risk |
| Capped Value | [$11.50 to $11.90] per unit, a return of [15.00% to 19.00%] over the principal amount, to be determined on the pricing date |
| Participation Rate | 300% |
| Preliminary Offering Documents | https://www.sec.gov/Archives/edgar/data/1000275/000095010325007843/dp230534_424b2-mlach.htm |
| Exchange Listing | No |
You should read the relevant Preliminary Offering Documents before you invest. Click on the Preliminary Offering Documents hyperlink above or call your Financial Advisor for a hard copy.
Risk Factors
Please see the Preliminary Offering Documents for a description of certain risks related to this investment, including, but not limited to, the following:
| · | Depending on the performance of the Market Measure as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal. |
| · | Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity. |
| · | Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. |
| · | Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the securities included in the Market Measure. |
| · | The initial estimated value of the notes is only an estimate, determined as of a particular point in time by reference to our and our affiliates’ pricing models. |
| · | The public offering price you pay for the notes will exceed the initial estimated value. |
| · | The initial estimated value does not represent a minimum or maximum price at which we, MLPF&S, BofAS or any of our affiliates would be willing to purchase your notes in any secondary market (if any exists) at any time. |
| · | A trading market is not expected to develop for the notes. |
| · | Our business, hedging and trading activities, and those of MLPF&S, BofAS and our respective affiliates (including trades in the securities included in the Market Measure), and any hedging and trading activities we, MLPF&S, BofAS or our respective affiliates engage in for our clients’ accounts, may affect the market value and return of the notes and may create conflicts of interest with you. |
| · | There may be potential conflicts of interest involving the calculation agent, which is BofAS. |
| · | The Market Measure sponsor may adjust the Market Measure in a way that affects its level, and has no obligation to consider your interests. |
| · | You will have no rights of a holder of the securities included in the Market Measure, and you will not be entitled to receive securities or dividends or other distributions by the issuers of those securities. |
| · | While we, MLPF&S, BofAS or our respective affiliates may from time to time own the securities included in the Market Measure, we, MLPF&S, BofAS and our respective affiliates do not control the issuers of those securities, and have not verified any disclosure made by any other company. |
| · | Your return on the notes and the value of the notes may be affected by exchange rate movements and factors affecting the international securities markets, specifically changes within the Eurozone. |
| · | The U.S. federal income tax consequences of an investment in the notes are uncertain. |
Final terms will be set on the pricing date within the given range for the specified Market-Linked Investment. Please see the Preliminary Offering Documents for complete product disclosure, including related risks and tax disclosure.
|
|
|
The graph above and the table below reflect the hypothetical return on the notes, based on the terms contained in the table to the left (using the mid-point for any range(s)). The graph and the table have been prepared for purposes of illustration only and do not take into account any tax consequences from investing in the notes. |
| Hypothetical Percentage Change from the Starting Value to the Ending Value | Hypothetical Redemption Amount per Unit | Hypothetical Total Rate of Return on the Notes |
| -100.00% | $0.00 | -100.00% |
| -50.00% | $5.00 | -50.00% |
| -20.00% | $8.00 | -20.00% |
| -10.00% | $9.00 | -10.00% |
| -6.00% | $9.40 | -6.00% |
| -3.00% | $9.70 | -3.00% |
| 0.00% | $10.00 | 0.00% |
| 2.00% | $10.60 | 6.00% |
| 3.00% | $10.90 | 9.00% |
| 5.00% | $11.50 | 15.00% |
| 5.67% | $11.70(1) | 17.00% |
| 10.00% | $11.70 | 17.00% |
| 20.00% | $11.70 | 17.00% |
| 30.00% | $11.70 | 17.00% |
| 50.00% | $11.70 | 17.00% |
| 100.00% | $11.70 | 17.00% |
| (1) | The Redemption Amount per unit cannot exceed the hypothetical Capped Value. |
| |
RBC has filed a registration statement (including a product supplement, a prospectus supplement and a prospectus) with the SEC for the offering to which this document relates. Before you invest, you should read those documents, and the other documents that RBC has filed with the SEC, for more complete information about RBC and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, RBC, any agent, or any dealer participating in this offering will arrange to send you these documents if you so request by calling toll-free 1-800-294-1322.
FAQ
What are RY's Accelerated Return Notes (ARNs) linked to EURO STOXX 50 offering in June 2025?
What is the maximum return potential for RY's EURO STOXX 50 linked ARNs?
What are the key risks of investing in RY's EURO STOXX 50 linked ARNs?
How does the payment structure work for RY's EURO STOXX 50 linked ARNs at maturity?
Will RY's EURO STOXX 50 linked ARNs be listed on an exchange?
